Yunbo Zhao
University of Science and Technology of China(CN)Tianjin University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Beijing Hospital(CN)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes, Genetic factors in colorectal cancer, Lung Cancer Treatments and Mutations, Legal and Regulatory Analysis
Most-Cited Works
- → The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients(1997)121 cited
- → First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer(2025)52 cited
- → Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter study(2021)29 cited
- Phase I safety and pharmacokinetic study of bevacizumab in Chinese patients with advanced cancer.(2010)
- → S-1 plus oxaliplatin versus S-1 plus cisplatin as first-line treatment for advanced diffuse-type or mixed-type gastric/gastroesophageal junction adenocarcinoma: A randomized, phase 3 trial.(2019)23 cited
- → Successful treatment with pazopanib plus PD-1 inhibitor and RAK cells for advanced primary hepatic angiosarcoma: a case report(2018)23 cited